Brian Gormley

Firm closes three new funds for venture, royalties and credit, and Asian investments

Jona and other startups aim to use AI to optimize microbiomes

Curie.Bio’s entrepreneur-friendly model helped lead to a recent funding round

Slowing U.S. venture investment spurs startups to consider investors from oil-rich country

Ajax, KKR and Hologic have launched a startup that advances lung-cancer devices and diagnostics

Orchid says its test sequences more than 99% of embryo genomes to screen for diseases

Fauna Bio compares genomic data from humans and other species to find drug targets. Its obesity research with collaborator Eli Lilly involves the 13-lined ground squirrel.

More accurate prognoses and treatments tailored to patients—entrepreneurs claim AI can be harnessed for breakthroughs in beating cancer. One founder is using lab-grown human organs in combination with AI to test drug efficacy.

Moonwalk and other biotech startups hope to treat diseases by activating beneficial genes and suppressing disease-causing ones

M&A and the prospect of an improved IPO market provide reasons for optimism